查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2099011

痔瘡治療器材市場 - 全球市場預測（2026-2032年）

Hemorrhoid Treatment Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，痔瘡治療器材市場將成長至 12.7526 億美元，複合年成長率為 6.01%。

主要市場統計數據
基準年 2025 8.4712億美元
預計年份：2026年 8.9967億美元
預測年份：2032年 1,275,260,000 美元
複合年成長率 (%) 6.01%

痔瘡治療器械，包括橡皮筋結紮系統、紅外線凝固裝置、雙極電凝裝置、多普勒引導痔動脈結紮系統、吻合器、雷射平台、冷凍治療裝置以及輔助肛門鏡和直腸鏡，用於透過門診手術、住院治療和外科手術等方式治療有症狀的內痔和外痔。這些器械的需求得到了充分的臨床支持。痔瘡在成人族群中十分普遍，在基層醫療、胃腸病學和大腸直腸外科等臨床領域均有報告。老齡化、便秘、懷孕、肥胖、長時間排便用力、久坐不動的生活方式和低纖維飲食都會增加痔瘡的風險。患者和臨床醫生越來越希望獲得更快的康復、更少的術後疼痛、更低的併發症風險以及微創治療途徑。日本消化學會和日本結直腸學會的臨床指南始終將保守治療作為一線治療方案，建議對許多有症狀的I至III級內痔患者進行門診手術，特別是橡皮筋結紮術。而手術治療則僅限於病情較重、復發、脫垂或伴隨併發症的病例。因此，痔瘡治療器械的市場趨勢主要受以下三個方面的影響：改善症狀管理、減少手術帶來的不適以及提高門診結直腸外科、消化內科和外科手術的運作效率。

痔瘡治療器材領域的變革性變化

痔瘡治療器械的模式正在從以醫院為中心的切除手術轉向更早、創傷更小、負擔更輕的治療方法，這些治療方法通常在門診、日間手術中心和私人診所進行。橡皮筋結紮術因其在臨床指南中的推薦、相對簡便的操作以及適用於多種內痔病例，仍被廣泛應用。然而，能量型和血管標靶技術日益受到臨床關注，醫療專業人員優先考慮止血、精準性和最大限度減少組織損傷。基於釘合器的痔瘡固定術和多普勒引導下的動脈結紮術促進了針對脫垂的治療策略的發展。同時，雷射痔瘡切除術和其他熱療方法正在接受評估，以檢視其恢復過程、疼痛緩解以及對特定患者的適用性。此外，醫療設備的引入決策越來越受到消毒要求、一次性器械與可重複使用器械的經濟性、醫生培訓負擔、保險報銷資格以及證據品質的影響。此外，病患的期望也正在改變醫療設備的採用趨勢。患者越來越傾向於從恢復時間、疼痛程度、復發風險、併發症以及能否儘早重返職場等角度來比較不同的治療方案。這些變化促使醫療設備開發商和醫療服務提供者設計出更適合門診使用、操作流程標準化、安全資訊記錄完善、易於臨床審核且以患者為中心的產品。

人工智慧對痔瘡治療的累積影響

人工智慧 (AI) 正開始間接影響痔瘡治療器械生態系統，其作用並非取代手術決策，而是促進診斷、分流、工作流程最佳化、記錄保存和證據生成。 AI 驅動的臨床決策支援系統能夠根據症狀嚴重程度、出血風險、便秘史、抗凝血劑使用情況、既往治療失敗情況以及觀察需要進行大腸鏡檢查或轉診至專科醫生的危險訊號，對患者進行分層。電腦輔助檢測工具正在增強內視鏡和影像相關工作流程中對結直腸病變的關注。這一點至關重要，因為痔瘡引起的直腸出血需要與其他胃腸道疾病（例如發炎性腸道疾病、肛裂、息肉和惡性腫瘤）相鑑別。自然語言處理有助於提高手術記錄的標準化程度、編碼準確性、術後追蹤、不利事件監測以及透過註冊登記進行的結果調查。在醫療設備研發領域，機器學習可用於識別復發模式、疼痛評分、出血控制、再次治療以及裝置相關事件，從而支援設計最佳化、材料測試、可用性評估、申訴趨勢分析和上市後監測。人工智慧的累積影響預計將在以下領域最為顯著：它能夠提高臨床一致性、減輕行政負擔，並為痔瘡治療醫療設備提供真實世界證據，同時確保醫生監督、資料隱私保護、偏差評估以及演算法推薦的透明度。

關於痔瘡治療設備的關鍵區域見解

在亞太地區，關鍵特徵包括專科醫療服務的普及、門診基礎設施的完善以及都市區對微創痔瘡治療日益成長的認知。中國、印度、日本、韓國、澳洲和東南亞等不同地區的醫療體系在推廣應用上有差異。成熟市場優先考慮品質保證和手術效率，而新興市場則更注重價格、培訓以及更廣泛的肛腸科服務。北美受益於成熟的結直腸外科和胃腸病學網路、完善的門診手術系統以及基於指南的臨床操作，例如針對不同嚴重程度痔瘡採用橡皮筋結紮術。該地區的推廣應用環境受到報銷制度、對醫療事故的敏感性、患者對無痛治療的高期望以及對循證技術的偏好等因素的影響。在拉丁美洲，雖然微創和門診痔瘡器材在私人醫療機構和都會醫院的使用率正在上升，但公立醫院的推廣應用很大程度上取決於採購預算、醫生培訓以及可重複使用或經濟實惠的器械的可用性。歐洲的醫療設備監管環境高度嚴格，其安全性、臨床證據、適用性評估和上市後監測是產品推廣應用的關鍵。西歐國家普遍擁有廣泛的先進大腸直腸外科手術資源，而東歐部分地區則更注重成本效益和醫院現代化。在中東，專科醫院的擴張、醫療旅遊走廊的興起以及對先進外科基礎設施的投資，正在推動尖端痔瘡治療器械的使用，尤其是在都市區三級醫療中心。非洲的情況則較為複雜，器械的應用主要集中在私立醫院和大型出版機構。更廣泛的應用與大腸直腸醫療保健專業人員的保障、診斷的可及性、價格的可負擔性、出版管道的暢通以及可靠的供應鏈密切相關。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協，痔瘡治療器械的普及應用正逐步推進，這得益於私立醫院網路的擴張、門診手術能力的提升以及對微創胃腸道和結直腸疾病治療需求的成長。然而，其普及程度會因醫療資金投入、專科醫生密度以及都市區地區的醫療資源可及性而有所不同。在海灣合作理事會（GCC）國家，先進的醫院基礎設施、便捷的專科醫生資源以及對高品質、低恢復時間手術的需求，共同促進了能量療法、結紮療法和外科痔瘡治療技術在設備完善的都市區醫療機構中的應用。歐盟（EU）的特點是醫療設備法規嚴格、對臨床證據有較高要求以及安全要求統一，因此，對於供應商而言，文件記錄、可追溯性、標籤標註和上市後性能評估至關重要。金磚國家（BRICS）的整體應用模式則呈現多樣性。中國和印度優先考慮規模化、價格可負擔性和擴大可及性。巴西支援透過公立和私立管道使用醫療設備。俄羅斯的情況則受到國內採購優先事項和醫療基礎設施分佈的影響。此外，南非的醫療器材應用主要集中在專科醫療機構和私人醫療機構。七國集團（G7）國家通常擁有成熟的法律規範體系、完善的結直腸疾病治療管道、先進的門診醫療基礎設施，並且對臨床證據的要求很高，因此，那些已被證實安全有效、治療效果可重複且能為臨床醫生培訓提供支持的醫療設備更受青睞。儘管北約成員國的醫療體系各不相同，但它們通用重視供應鏈的韌性、監管合規性、醫院的準備情況、採購流程的透明度以及標準化的臨床醫生培訓，所有這些因素都會影響痔瘡治療醫療設備的持續供應。

各國關於痔瘡治療器材引進情況的關鍵訊息

在美國，痔瘡治療器材的門診和日間手術環境已相當成熟，臨床實踐受結直腸和胃腸病學指南、患者快速康復的需求以及適用於內痔的門診治療的廣泛應用所指導。在加拿大，由於公共醫療系統的覆蓋範圍因省份而異，高效的門診治療對於減輕手術負擔並維持醫療品質至關重要。在墨西哥，由於接近性先進醫療設備供應鏈以及對經濟實惠、微創手術的需求，私立醫院和都市區專科診所對痔瘡治療器材的應用正在不斷擴展。與其他拉丁美洲國家相比，巴西的專科醫療體系相對完善，但痔瘡治療器材的使用受到私部門器材供應充足與公部門採購限制之間差異的影響。在英國，重點在於實證臨床路徑、高效傳播和合理使用手術干預措施，其應用受到國家醫療體系優先事項和候診名單壓力的影響。德國擁有高度發展的醫院和門診專科醫療基礎設施、全面的外科培訓以及嚴格的醫療設備品質標準。在法國、義大利和西班牙，結直腸醫療保健系統已經相當完善，醫療設備的選擇受到保險報銷、醫生水平以及對兼顧復發預防和術後舒適度的手術方案的偏好等因素的影響。在俄羅斯，醫療器材的普及應用受到區域醫療保健差異、採購政策以及主要大都市地區訓練有素的專科醫生數量的影響。在中國，隨著醫院現代化和城市醫療網路的建設，肛腸科和胃腸道醫療保健服務的覆蓋範圍正在擴大，但國內生產能力和成本因素影響著採購模式。在印度，由於生活方式和飲食相關的風險因素，痔瘡治療的需求非常高，對私人醫院、門診手術中心和快速康復的需求推動了醫療器械的普及，但價格承受能力和臨床醫生培訓仍然是重要的決定因素。在日本和韓國，先進的醫療技術環境以及對精準性、安全性和病患舒適度的高要求，推動了最新結紮器械、能量器械和外科手術器械的選擇性應用。在澳大利亞，專業的結直腸護理服務、私立醫院的普及以及基於指南的醫療服務為這些器械的推廣提供了支持，而地理分佈則影響了主要城市以外地區患者的就醫途徑。

業界領導者使用的實用建議

產業領導者應優先考慮經臨床檢驗的產品系列，涵蓋痔瘡治療的整個流程，從低成本的診所結紮系統到先進的能量療法和複雜疾病的外科手術方案。醫療設備策略應著重於基於患者報告的疼痛和出血緩解情況、脫垂改善情況、復發率、恢復活動時間、併發症率、再次手術頻率以及（如有可能）長期追蹤等數據來獲取證據。培訓是促進產品推廣的關鍵因素。製造商和經銷商應為結直腸外科醫生、胃腸病學家和普通外科醫生提供標準化的操作培訓、模擬訓練、指導、能力認證和清晰的患者選擇指南。銷售團隊需要根據當地的採購情況調整產品系列，在一次性產品的便利性和可重複使用產品的成本效益之間取得平衡，尤其是在新興市場。監管團隊必須維持強力的上市後監測，包括不利事件報告、滅菌驗證、生物相容性文件和易用性證據，尤其是在醫療設備監管嚴格的地區。數位化能力，例如人工智慧驅動的病歷記錄、治療結果追蹤、庫存規劃和患者隨訪，應在保護高度敏感的醫療數據的前提下負責任地開發。最後，領導者應加強耗材、帶狀物、探針、纖維、縫合組件和無菌相容配件等供應鏈的韌性，因為治療的連續性對於門診效率和醫護人員的信任至關重要。

調查方法

本執行摘要採用系統的二手研究方法編寫，所用資料均來自公開檢驗的資訊來源，包括臨床實踐指南、同行評審的醫學文獻、法律規範、公共衛生參考資料、醫院手術標準和醫療設備安全文件。分析重點在於與痔瘡治療、微創肛腸科、門診手術普及、醫療設備安全、病患預後、感染預防和當地醫療基礎設施相關的研究途徑。本摘要未列出市場規模、市場佔有率、收入估計或未來預測。區域、群體和國家層面的洞察分析從醫療服務可近性、監管成熟度、報銷環境、臨床醫生培訓體系、門診醫療基礎設施、採購條件和技術應用趨勢等方面展開。調查方法強調交叉檢驗臨床和政策訊號，剔除未經證實的標語，並與實證醫學和醫療設備評估領域的權威標準保持一致。

結論

在以微創手術、簡化門診護理和以病人為中心的復健為核心的醫療環境下，痔瘡治療器材也不斷發展。雖然橡皮筋結紮術和其他門診手術仍然是治療內痔的主要方法，但能量型技術、多普勒導引技術、吻合器技術和雷射技術仍然是治療晚期或特定病例的主要選擇。這些技術的應用可行性更取決於臨床證據、培訓、安全性、醫保報銷相容性、消毒可行性和工作流程優勢，而不僅僅是技術新穎性。區域差異顯著；成熟的醫療體系優先考慮實證醫學和品管，而新興市場則優先考慮可負擔性、可近性和可擴展的醫護人員培訓。人工智慧（AI）將日益增強診斷分診、病歷記錄、上市後監測和真實世界證據的構建，但治療效果仍將取決於患者的合理選擇和熟練的臨床操作。擁有檢驗的醫療設備、全面的培訓計劃、負責任的數位整合以及強大的供應鏈的行業相關人員被認為最有能力支持現代痔瘡治療。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 痔瘡治療器材市場：依產品類型分類

  • 冷凍療法設備
    • 氣體壓縮型
    • 液態氮型
  • 痔瘡切除設備
    • 結紮設備
    • 訂書機設備
    • 傳統手術刀
  • 紅外線凝固設備
    • 接觸式紅外線凝固設備
    • 非接觸式紅外線凝固設備
  • 雷射治療設備
    • 二氧化碳雷射治療儀
    • 二極體雷射治療設備
    • Nd:YAG雷射治療儀
  • 橡皮筋結紮設備
  • 用於硬化療法的醫療設備
    • 乙氧硬化劑注射器
    • 聚多卡醇注射器

第8章 痔瘡治療器材市場：依支付方分類

  • 公共保險
    • 醫療補助
    • 聯邦醫療保險
  • 自費
    • 支援計劃
    • 自費
  • 私人保險
    • 雇主出資的保險
    • 個人保險計劃

第9章 痔瘡治療器材市場：依最終用戶分類

  • 門診手術中心
    • 醫院營運的日間手術中心
    • 由醫師擁有的門診手術中心
  • 診所
    • 一般診所
    • 直腸科診所
  • 居家醫療
    • 由護理師管理
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第10章 痔瘡治療器材市場：依分銷管道分類

  • 線上
  • 離線

第11章 痔瘡治療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 痔瘡治療器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 痔瘡治療器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • AMI Agency for Medical Innovations GmbH
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BOWA-electronic GmbH & Co. KG
  • CONMED Corporation
  • Cook Medical
  • Erbe Elektromedizin GmbH
  • Hologic Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medline Industries LP
  • Medtronic plc
  • Mermaid Medical A/S
  • Olympus Corporation
  • Privi Medical
  • Purple Surgical
  • Renew Medical Inc.
  • Richard Wolf GmbH
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Teleflex Incorporated
Product Code: MRR-450A0628DDAC

The Hemorrhoid Treatment Devices Market is projected to grow by USD 1,275.26 million at a CAGR of 6.01% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 847.12 million
Estimated Year [2026] USD 899.67 million
Forecast Year [2032] USD 1,275.26 million
CAGR (%) 6.01%

Hemorrhoid treatment devices are used to manage symptomatic internal and external hemorrhoids through office-based, ambulatory, and surgical interventions, including rubber band ligation systems, infrared coagulation instruments, bipolar and electrotherapy devices, Doppler-guided hemorrhoidal artery ligation systems, stapling devices, laser platforms, cryotherapy tools, and ancillary anoscopes or proctoscopes. Demand for these devices is supported by well-documented clinical drivers: hemorrhoidal disease is common in adult populations, with prevalence reported across primary care, gastroenterology, and colorectal practice, and risk increases with age, constipation, pregnancy, obesity, prolonged straining, sedentary behavior, and low-fiber diets. Patients and clinicians increasingly seek faster recovery, reduced postoperative pain, lower complication risk, and minimally invasive care pathways. Clinical guidelines from gastroenterology and colorectal surgery societies consistently position conservative therapy as first-line management and recommend office-based procedures, particularly rubber band ligation, for many patients with symptomatic grade I to III internal hemorrhoids, while operative technologies are reserved for advanced, recurrent, prolapsing, or complicated disease. The executive landscape for hemorrhoid treatment devices is therefore shaped by three converging priorities: improved symptom control, reduced procedure-related discomfort, and workflow efficiency for outpatient colorectal, gastroenterology, and surgical practices.

Transformative Shifts in the Hemorrhoid Treatment Device Landscape

The hemorrhoid treatment devices landscape is shifting from hospital-centric excisional surgery toward earlier, less invasive, and more patient-friendly interventions delivered in outpatient departments, ambulatory surgery centers, and office settings. Rubber band ligation remains widely used because it is guideline-supported, comparatively simple, and suitable for a broad portion of internal hemorrhoid cases; however, energy-based and vessel-targeting techniques are gaining clinical attention where providers prioritize hemostasis, precision, and reduced tissue trauma. Stapled hemorrhoidopexy and Doppler-guided hemorrhoidal artery ligation have contributed to the evolution of prolapse-focused treatment strategies, while laser hemorrhoidoplasty and other thermal approaches are being assessed for recovery profile, pain reduction, and suitability in selected patients. At the same time, procurement decisions increasingly depend on sterilization requirements, disposable versus reusable economics, physician training burden, reimbursement compatibility, and evidence quality. Patient expectations are also transforming device adoption as individuals increasingly compare treatment options based on downtime, pain, recurrence risk, complications, and the ability to return quickly to work. These shifts are encouraging device developers and care providers to align product design with outpatient throughput, standardized technique, safety documentation, clinical auditability, and patient-centered outcomes.

Cumulative Impact of Artificial Intelligence on Hemorrhoid Care

Artificial intelligence is beginning to influence the hemorrhoid treatment device ecosystem indirectly through diagnostics, triage, workflow optimization, documentation, and evidence generation rather than replacing procedural judgment. AI-enabled clinical decision support can help stratify patients by symptom severity, bleeding risk, constipation history, anticoagulant use, prior treatment failure, and red-flag features that require colonoscopic evaluation or specialist referral. In endoscopy and imaging-adjacent workflows, computer-aided detection tools are strengthening attention to colorectal pathology, which is important because rectal bleeding attributed to hemorrhoids must be differentiated from other gastrointestinal conditions, including inflammatory bowel disease, fissures, polyps, and malignancy. Natural language processing can improve procedure note standardization, coding accuracy, post-procedure follow-up, adverse event monitoring, and registry-based outcomes research. In device development, machine learning can support design optimization, material testing, usability assessment, complaint trending, and post-market surveillance by identifying patterns in recurrence, pain scores, bleeding control, reintervention, and device-related events. The cumulative impact of AI will be strongest where it improves clinical consistency, reduces administrative friction, and supports real-world evidence for hemorrhoid treatment devices, while maintaining physician oversight, data privacy protections, bias assessment, and transparency in algorithmic recommendations.

Key Regional Insights for Hemorrhoid Treatment Devices

Asia-Pacific is characterized by rising access to specialist care, expanding ambulatory infrastructure, and growing awareness of minimally invasive hemorrhoid procedures in urban centers. China, India, Japan, South Korea, Australia, and Southeast Asian health systems show different adoption pathways, with mature markets emphasizing quality assurance and procedural efficiency and emerging markets prioritizing affordability, training, and broader access to proctology services. North America benefits from established colorectal surgery and gastroenterology networks, strong outpatient procedure capacity, and guideline-based use of office procedures such as rubber band ligation for appropriate internal hemorrhoid grades. The region's adoption environment is influenced by reimbursement structures, malpractice sensitivity, high patient expectations for low-pain treatment, and a preference for evidence-backed technologies. Latin America demonstrates increasing use of minimally invasive and office-based hemorrhoid treatment devices in private healthcare networks and metropolitan hospitals, while public sector adoption is more dependent on procurement budgets, physician training, and availability of reusable or cost-efficient systems. Europe reflects a highly regulated environment where device safety, clinical evidence, conformity assessment, and post-market surveillance are central to adoption, with Western European countries generally showing broader access to advanced colorectal procedures and parts of Eastern Europe emphasizing cost-effectiveness and hospital modernization. In the Middle East, specialist hospital expansion, medical tourism corridors, and investment in advanced surgical infrastructure support the use of modern hemorrhoid treatment devices, particularly in urban tertiary centers. Africa presents a more heterogeneous landscape, with adoption concentrated in private hospitals and major referral centers; broader utilization is linked to colorectal workforce availability, diagnostic access, affordability, referral pathways, and supply-chain reliability.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN countries are advancing hemorrhoid treatment device adoption through expanding private hospital networks, growing ambulatory surgery capacity, and increasing demand for minimally invasive gastrointestinal and colorectal interventions, although adoption varies by healthcare financing, specialist density, and urban-rural access. The GCC shows strong alignment with advanced hospital infrastructure, specialist recruitment, and demand for high-quality, low-downtime procedures, supporting uptake of energy-based, ligation, and surgical hemorrhoid technologies in well-equipped urban facilities. The European Union is shaped by stringent medical device regulation, clinical evidence expectations, and harmonized safety requirements, making documentation, traceability, labeling, and post-market performance essential for suppliers. BRICS economies collectively represent diverse adoption conditions: China and India emphasize scale, affordability, and expanding access; Brazil supports device use through both private and public pathways; Russia's environment is influenced by domestic procurement priorities and healthcare infrastructure distribution; and South Africa's uptake is concentrated in specialist and private care settings. G7 countries typically feature mature regulatory oversight, established colorectal care pathways, advanced ambulatory infrastructure, and high expectations for clinical evidence, which favor devices with documented safety, procedural efficiency, reproducible outcomes, and clinician training support. NATO member countries include varied healthcare systems but commonly prioritize supply-chain resilience, regulatory compliance, hospital readiness, procurement transparency, and standardized clinician training, all of which affect continuity of hemorrhoid treatment device availability.

Key Country Insights for Hemorrhoid Treatment Device Adoption

The United States has a strong outpatient and ambulatory surgery environment for hemorrhoid treatment devices, with clinical practice shaped by colorectal and gastroenterology guidelines, patient demand for rapid recovery, and extensive use of office-based procedures for eligible internal hemorrhoids. Canada reflects a publicly funded healthcare context where access can vary by province, making efficient outpatient interventions valuable for reducing surgical burden while maintaining quality standards. Mexico shows growing adoption in private hospitals and urban specialty clinics, supported by proximity to advanced device supply chains and demand for cost-conscious minimally invasive procedures. Brazil has one of Latin America's more developed specialist care environments, with hemorrhoid device utilization influenced by the contrast between private-sector availability and public-sector procurement constraints. The United Kingdom emphasizes evidence-based clinical pathways, referral efficiency, and appropriate use of procedural interventions, with adoption shaped by national health system priorities and waiting-list pressures. Germany benefits from a highly developed hospital and ambulatory specialist infrastructure, strong surgical training, and rigorous device quality expectations. France, Italy, and Spain demonstrate established colorectal care capabilities, with device selection influenced by reimbursement, physician familiarity, and preference for techniques that balance recurrence control with postoperative comfort. Russia's adoption environment is shaped by regional healthcare disparities, procurement policy, and availability of trained specialists in major urban centers. China is expanding access to proctology and gastrointestinal care through hospital modernization and large urban healthcare networks, while domestic manufacturing capability and cost sensitivity influence purchasing patterns. India shows substantial need for hemorrhoid care due to lifestyle and dietary risk factors, with adoption driven by private hospitals, day-care surgery centers, and demand for faster recovery, while affordability and clinician training remain key determinants. Japan and South Korea combine advanced medical technology environments with strong expectations for precision, safety, and patient comfort, supporting selective adoption of modern ligation, energy-based, and surgical devices. Australia's adoption is supported by specialist colorectal services, private hospital access, and guideline-based care, with geographic distribution influencing access outside major cities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated product portfolios that address the full continuum of hemorrhoid care, from low-cost office-based ligation systems to advanced energy-based and surgical solutions for complex disease. Device strategies should emphasize evidence generation using patient-reported pain, bleeding resolution, prolapse improvement, recurrence, return-to-activity time, complication rates, reintervention frequency, and long-term follow-up where feasible. Training is a decisive adoption lever: manufacturers and distributors should support standardized procedural education, simulation, proctoring, competency documentation, and clear patient-selection guidance for colorectal surgeons, gastroenterologists, and general surgeons. Commercial teams should adapt portfolios to local purchasing realities by balancing disposable convenience with reusable affordability, particularly in emerging markets. Regulatory teams must maintain strong post-market surveillance, adverse event reporting, sterilization validation, biocompatibility documentation, and usability evidence, especially in regions with tightening device oversight. Digital capabilities should be developed responsibly, including AI-supported documentation, outcomes tracking, inventory planning, and patient follow-up, while protecting sensitive health data. Finally, leaders should strengthen supply-chain resilience for consumables, bands, probes, fibers, stapling components, and sterilization-compatible accessories, because procedure continuity is essential for outpatient productivity and provider trust.

Research Methodology

This executive summary is developed through a structured secondary research approach using publicly available and verifiable sources, including clinical practice guidelines, peer-reviewed medical literature, regulatory frameworks, public health references, hospital procedure standards, and medical device safety documentation. The analysis prioritizes evidence related to hemorrhoidal disease management, minimally invasive proctology, outpatient procedure adoption, device safety, patient outcomes, infection prevention, and regional healthcare infrastructure. Information is synthesized without presenting market sizing, market share, revenue estimates, or forecasts. Regional, group, and country insights are interpreted through healthcare access, regulatory maturity, reimbursement environment, clinician training capacity, ambulatory infrastructure, procurement conditions, and technology adoption patterns. The methodology emphasizes cross-validation of clinical and policy signals, exclusion of unsupported promotional claims, and alignment with recognized standards in evidence-based medicine and medical device evaluation.

Conclusion

Hemorrhoid treatment devices are evolving within a healthcare environment that favors minimally invasive intervention, outpatient efficiency, and patient-centered recovery. Rubber band ligation and other office-based procedures remain central for suitable internal hemorrhoids, while energy-based, Doppler-guided, stapling, and laser technologies continue to shape treatment options for more advanced or selected cases. Adoption depends less on novelty alone and more on clinical evidence, training, safety, reimbursement fit, sterilization practicality, and workflow benefits. Regional differences are substantial, with mature healthcare systems emphasizing evidence and quality control, while emerging markets prioritize affordability, access, and scalable clinician education. Artificial intelligence will increasingly strengthen diagnostic triage, documentation, post-market surveillance, and real-world evidence development, but procedural outcomes will continue to depend on appropriate patient selection and skilled clinical execution. Industry participants that combine validated devices, strong training ecosystems, responsible digital integration, and resilient supply chains will be best positioned to support modern hemorrhoid care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Hemorrhoid Treatment Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Cryotherapy Devices
    • 7.2.1. Gas Compression Based
    • 7.2.2. Liquid Nitrogen Based
  • 7.3. Hemorrhoidectomy Devices
    • 7.3.1. Ligasure Devices
    • 7.3.2. Stapler Devices
    • 7.3.3. Traditional Scalpel Instruments
  • 7.4. Infrared Coagulation Devices
    • 7.4.1. Contact Infrared Coagulation
    • 7.4.2. Non-Contact Infrared Coagulation
  • 7.5. Laser Treatment Devices
    • 7.5.1. CO2 Laser Devices
    • 7.5.2. Diode Laser Devices
    • 7.5.3. Nd:YAG Laser Devices
  • 7.6. Rubber Band Ligation Devices
  • 7.7. Sclerotherapy Devices
    • 7.7.1. Aethoxysklerol Syringes
    • 7.7.2. Polidocanol Syringes

8. Hemorrhoid Treatment Devices Market, by Payer Type

  • 8.1. Introduction
  • 8.2. Government Insurance
    • 8.2.1. Medicaid
    • 8.2.2. Medicare
  • 8.3. Out-of-Pocket
    • 8.3.1. Assistance Programs
    • 8.3.2. Self-Pay
  • 8.4. Private Insurance
    • 8.4.1. Employer-Funded Plans
    • 8.4.2. Individual Plans

9. Hemorrhoid Treatment Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
    • 9.2.1. Hospital-Owned ASC
    • 9.2.2. Physician-Owned ASC
  • 9.3. Clinics
    • 9.3.1. General Clinics
    • 9.3.2. Proctology Clinics
  • 9.4. Home Care Settings
    • 9.4.1. Nurse-Administration
    • 9.4.2. Self-Administration
  • 9.5. Hospitals
    • 9.5.1. Private Hospitals
    • 9.5.2. Public Hospitals

10. Hemorrhoid Treatment Devices Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online
  • 10.3. Offline

11. Hemorrhoid Treatment Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Hemorrhoid Treatment Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Hemorrhoid Treatment Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. A.M.I. Agency for Medical Innovations GmbH
  • 15.2. B. Braun Melsungen AG
  • 15.3. Boston Scientific Corporation
  • 15.4. BOWA-electronic GmbH & Co. KG
  • 15.5. CONMED Corporation
  • 15.6. Cook Medical
  • 15.7. Erbe Elektromedizin GmbH
  • 15.8. Hologic Inc.
  • 15.9. Integra LifeSciences Corporation
  • 15.10. Johnson & Johnson
  • 15.11. Karl Storz SE & Co. KG
  • 15.12. Medline Industries LP
  • 15.13. Medtronic plc
  • 15.14. Mermaid Medical A/S
  • 15.15. Olympus Corporation
  • 15.16. Privi Medical
  • 15.17. Purple Surgical
  • 15.18. Renew Medical Inc.
  • 15.19. Richard Wolf GmbH
  • 15.20. Sklar Surgical Instruments
  • 15.21. Smith & Nephew plc
  • 15.22. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CRYOTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRYOTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CRYOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GAS COMPRESSION BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GAS COMPRESSION BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GAS COMPRESSION BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIQUID NITROGEN BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIQUID NITROGEN BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID NITROGEN BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMORRHOIDECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMORRHOIDECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMORRHOIDECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIGASURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIGASURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIGASURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STAPLER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STAPLER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STAPLER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TRADITIONAL SCALPEL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRADITIONAL SCALPEL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TRADITIONAL SCALPEL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INFRARED COAGULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INFRARED COAGULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INFRARED COAGULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONTACT INFRARED COAGULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTACT INFRARED COAGULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONTACT INFRARED COAGULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-CONTACT INFRARED COAGULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-CONTACT INFRARED COAGULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-CONTACT INFRARED COAGULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LASER TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LASER TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LASER TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CO2 LASER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CO2 LASER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CO2 LASER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIODE LASER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIODE LASER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIODE LASER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ND:YAG LASER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ND:YAG LASER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ND:YAG LASER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RUBBER BAND LIGATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RUBBER BAND LIGATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RUBBER BAND LIGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SCLEROTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SCLEROTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SCLEROTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AETHOXYSKLEROL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AETHOXYSKLEROL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AETHOXYSKLEROL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLIDOCANOL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLIDOCANOL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POLIDOCANOL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GOVERNMENT INSURANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GOVERNMENT INSURANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GOVERNMENT INSURANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OUT-OF-POCKET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OUT-OF-POCKET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OUT-OF-POCKET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ASSISTANCE PROGRAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ASSISTANCE PROGRAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ASSISTANCE PROGRAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SELF-PAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SELF-PAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SELF-PAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PRIVATE INSURANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PRIVATE INSURANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PRIVATE INSURANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EMPLOYER-FUNDED PLANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EMPLOYER-FUNDED PLANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EMPLOYER-FUNDED PLANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDIVIDUAL PLANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INDIVIDUAL PLANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INDIVIDUAL PLANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITAL-OWNED ASC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITAL-OWNED ASC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITAL-OWNED ASC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHYSICIAN-OWNED ASC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHYSICIAN-OWNED ASC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHYSICIAN-OWNED ASC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENERAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GENERAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GENERAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PROCTOLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PROCTOLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PROCTOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NURSE-ADMINISTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NURSE-ADMINISTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NURSE-ADMINISTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SELF-ADMINISTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SELF-ADMINISTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SELF-ADMINISTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 261. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 305. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 309. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 311. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 312. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 313. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 315. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 316. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 317. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 318. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 320. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 325. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 326. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 328. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 329. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 330. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 331. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 332. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 333. NATO HEM